The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Axcella Health Inc | COM | 05454B105 | 3,960,427 | 18,142,125 | SH | DFND | 2,3 | 0 | 18,142,125 | 0 | ||
| Axcella Health Inc | COM | 05454B105 | 2,425,187 | 11,109,420 | SH | DFND | 3 | 0 | 11,109,420 | 0 | ||
| Denali Therapeutics Inc | COM | 24823R105 | 77,315,256 | 2,619,968 | SH | DFND | 1,3 | 0 | 2,619,968 | 0 | ||
| Evelo Biosciences Inc | COM | 299734202 | 1,651,436 | 508,134 | SH | DFND | 2,3 | 0 | 508,134 | 0 | ||
| Evelo Biosciences Inc | COM | 299734202 | 1,658,362 | 510,265 | SH | DFND | 1,3 | 0 | 510,265 | 0 | ||
| Evelo Biosciences Inc | COM | 299734202 | 4,884,654 | 1,502,970 | SH | DFND | 3 | 0 | 1,502,970 | 0 | ||
| Foghorn Therapeutics Inc | COM | 344174107 | 65,689,381 | 9,330,878 | SH | DFND | 1,3 | 0 | 9,330,878 | 0 | ||
| Foghorn Therapeutics Inc | COM | 344174107 | 23,536,424 | 3,343,242 | SH | DFND | 3 | 0 | 3,343,242 | 0 | ||
| Moderna Inc | COM | 60770K107 | 1,565,262,509 | 12,882,819 | SH | DFND | 2,3 | 0 | 12,882,819 | 0 | ||
| Moderna Inc | COM | 60770K107 | 476,766 | 3,924 | SH | DFND | 3 | 0 | 3,924 | 0 | ||
| Omega Therapeutics Inc | COM | 68217N105 | 39,115,194 | 6,984,856 | SH | DFND | 1,3 | 0 | 6,984,856 | 0 | ||
| Omega Therapeutics Inc | COM | 68217N105 | 124,548,049 | 22,240,723 | SH | DFND | 3 | 0 | 22,240,723 | 0 | ||
| Sana Biotechnology Inc | COM | 799566104 | 72,256,477 | 12,123,570 | SH | DFND | 1,3 | 0 | 12,123,570 | 0 | ||
| Sana Biotechnology Inc | COM | 799566104 | 126,152,030 | 21,166,448 | SH | DFND | 3 | 0 | 21,166,448 | 0 | ||
| Seres Therapeutics Inc | COM | 81750R102 | 40,489,276 | 8,452,876 | SH | DFND | 2,3 | 0 | 8,452,876 | 0 | ||
| Seres Therapeutics Inc | COM | 81750R102 | 70,241,370 | 14,664,169 | SH | DFND | 3 | 0 | 14,664,169 | 0 | ||
| Sigilon Therapeutics Inc | COM | 82657L206 | 15,391,438 | 683,760 | SH | DFND | 1,3 | 0 | 683,760 | 0 | ||
| Sigilon Therapeutics Inc | COM | 82657L206 | 2,565,240 | 113,960 | SH | DFND | 3 | 0 | 113,960 | 0 | ||
| Syros Pharmaceuticals Inc | COM | 87184Q206 | 925,622 | 293,848 | SH | DFND | 2,3 | 0 | 293,848 | 0 | ||
| Syros Pharmaceuticals Inc | COM | 87184Q206 | 2,205,000 | 700,000 | SH | DFND | 3 | 0 | 700,000 | 0 | ||